Pfizer has reportedly produced ‘several hundred thousand’ Kovid-19 vaccines, reflecting the November regulatory hiatus.

Top Line

US drug giant Pfizer has begun manufacturing hundreds of thousands of Kovid-19 vaccines before an expected US approval in November. Mail on sunday Report.

Key Facts

Coronovirus vaccine is being manufactured according to the company’s factory in Purse, Belgium Mail on sunday, who Interviewed Pfizer’s UK head Ben Osborne and showed a video showing Pfizer’s manufacturing process, although it is unclear whether the clip showed the production of the Kovid-19 vaccine.

The company says it expects to make 100 million doses available this year, should the vaccine be given regulatory approval, with plans to manufacture 1.3 billion in 2021.

Each patient will need to take two doses of the vaccine, according to Mail on sunday.

Now produced vaccines are being stocked, and ready to ship worldwide if going ahead Mail on sunday Report good.

A Pfizer spokesperson told Forbes that the video accompanies Mail on sundayOf The article did not produce the Kovid-19 vaccine.

Main background

Pfizer is at the forefront of the global race to develop a safe and effective Kovid-19 vaccine, which it is developing with Bioentech in Germany. The approval has not yet been received, but production comes ahead of an anticipated approval in the US when the company goes into effect in mid-November. Last week, the company’s CEO publicly clarified his best guesses as to when he could apply for emergency approval, a thinly condescending criticism of President Trump, which is prompting the vaccination, 3 November Will be ready and available before the election of. According to Pfizer’s best estimate, the third week of November would be the first time they would be able to apply for approval.

Further studies

The world is longing to see the video … Kovid vaccines are rolling out the Pfizer production line in thousands of small bottles as the professor claims the Oxford-Astra Zeneca shot will be rolled out by Dembeur (Mail on Sunday).

Pfizer will seek emergency approval for the Kovid-19 vaccine after the election in November (Forbes)

Full coverage and live updates on Coronavirus


Leave a Reply

Your email address will not be published.